NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors-A Retrospective Molecular Tumor Board Analysis

Precision oncology treatments are being applied more commonly in breast and gynecological oncology through the implementation of Molecular Tumor Boards (MTBs), but real-world clinical outcome data remain limited. A retrospective analysis was conducted in patients with breast cancer (BC) and gynecolo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2024-04, Vol.16 (8), p.1561
Hauptverfasser:	Gremke, Niklas, Rodepeter, Fiona R, Teply-Szymanski, Julia, Griewing, Sebastian, Boekhoff, Jelena, Stroh, Alina, Tarawneh, Thomas S, Riera-Knorrenschild, Jorge, Balser, Christina, Hattesohl, Akira, Middeke, Martin, Ross, Petra, Litmeyer, Anne-Sophie, Romey, Marcel, Stiewe, Thorsten, Wündisch, Thomas, Neubauer, Andreas, Denkert, Carsten, Wagner, Uwe, Mack, Elisabeth K M
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers BRCA1 protein Breast cancer Cancer therapies Clinical trials Consortia FDA approval Genes Gynecology Malignancy Metastases Metastasis Mutation Next-generation sequencing Oncology Ovarian cancer p53 Protein Patients Precision medicine Survival Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!